Management of uterine adenosarcomas with and without sarcomatous overgrowth Academic Article uri icon

Overview

MeSH Major

  • Adenosarcoma
  • Uterine Neoplasms

abstract

  • Unlike AS without sarcomatous overgrowth, AS+SO is an aggressive disease with a high recurrence rate. In our series, no optimal adjuvant or systemic treatment strategy was identifiable but standard sarcoma chemotherapy regimens appear to have efficacy in both AS and AS+SO.

publication date

  • April 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2012.12.036

PubMed ID

  • 23283300

Additional Document Info

start page

  • 140

end page

  • 4

volume

  • 129

number

  • 1